These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunological studies on an Egyptian bivalent Naja antivenin. Mohamed AH; Darwish MA; Hani-Ayobe M Toxicon; 1974 May; 12(3):321-3. PubMed ID: 4458113 [No Abstract] [Full Text] [Related]
5. Protection against sea snake envenomation: comparative potency of four antivenenes. Baxter EH; Gallichio HA Toxicon; 1976 Aug; 14(5):347-55. PubMed ID: 982475 [No Abstract] [Full Text] [Related]
6. The production and characteristics of a coral snake (Micrurus mipartitus Hertwigi) antivenin. Bolaños R; Cerdas L; Taylor R Toxicon; 1975 Mar; 13(2):139-42. PubMed ID: 1129821 [No Abstract] [Full Text] [Related]
7. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines. Seddik SS; Wanas S; Helmy MH; Hashem M J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876 [TBL] [Abstract][Full Text] [Related]
9. Immunological studies on monovalent and bivalent Cerastes antivenin. Mohamed AH; Abdel-Baset A; Hassan A Toxicon; 1980; 18(3):384-7. PubMed ID: 6771891 [No Abstract] [Full Text] [Related]
10. Diversity of Micrurus snake species related to their venom toxic effects and the prospective of antivenom neutralization. Tanaka GD; Furtado Mde F; Portaro FC; Sant'Anna OA; Tambourgi DV PLoS Negl Trop Dis; 2010 Mar; 4(3):e622. PubMed ID: 20231886 [TBL] [Abstract][Full Text] [Related]
11. Preclinical assessment of the neutralizing efficacy of snake antivenoms in Latin America and the Caribbean: A review. Gutiérrez JM Toxicon; 2018 May; 146():138-150. PubMed ID: 29510161 [TBL] [Abstract][Full Text] [Related]
12. Neutralization of old world viper venoms by American pit viper antivenin. Minton SA Toxicon; 1976; 14(2):146-8. PubMed ID: 1273862 [No Abstract] [Full Text] [Related]
13. [Hematologic values and serum enzymes in horses inoculated with snake venoms for the production of antivenins in Costa Rica]. Estrada R; Chaves F; Robles A; Rojas E; Segura E; Gutiérrez JM Rev Biol Trop; 1992 Apr; 40(1):95-9. PubMed ID: 1297173 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom. Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805 [TBL] [Abstract][Full Text] [Related]
15. New techniques in antivenom production and active immunization against snake venoms. Theakston RD Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474 [No Abstract] [Full Text] [Related]
20. Efficacy of Haffkine Institute polyvalent antivenin against Indian snake venoms. Kankonkar RC; Rao SS; Vad NE; Sant MV Indian J Med Res; 1972 Apr; 60(4):512-6. PubMed ID: 4633900 [No Abstract] [Full Text] [Related] [Next] [New Search]